According to recent filings covering the 90 days ending February 07, 2026, the three most significant insider holders at Allogene Therapeutics are President And Ceo David D Chang (5.19Mn shares), Director Arie Belldegrun (3.96Mn shares), Chief Financial Officer Geoffrey M. Parker (1.25Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| David D Chang | President And Ceo | 5,185,862 | 04 Feb, 2026 |
| Arie Belldegrun | 3,960,953 | 28 Jan, 2025 | |
| Geoffrey M. Parker | Chief Financial Officer | 1,252,795 | 04 Feb, 2026 |
| Eric Thomas Schmidt | Chief Financial Officer | 862,439 | 24 Mar, 2023 |
| Alison Moore | Chief Technical Officer | 672,731 | 24 Mar, 2023 |
| Zachary Roberts | Evp Of R&D | 581,166 | 04 Feb, 2026 |
| Earl Martin Douglas | Svp And General Counsel | 564,948 | 04 Feb, 2026 |
| Veer Bhavnagri | General Counsel | 556,049 | 16 Mar, 2023 |
| Rafael Amado | Evp Of R&D | 541,946 | 11 Oct, 2022 |
| Joshua A Kazam | 350,763 | 22 Dec, 2025 | |
| Franz B Humer | 307,507 | 09 Dec, 2024 | |
| Owen N. Witte | 292,832 | 15 Jun, 2023 | |
| Timothy L. Moore | Chief Technical Officer | 250,713 | 05 Feb, 2025 |
| Benjamin Machinas Beneski | Svp And Chief Technical Officer | 210,172 | 04 Feb, 2026 |
| Vicki L Sato | 162,575 | 07 Jun, 2024 | |
| Lillian Smith | Vp And Corporate Counsel | 140,390 | 05 Apr, 2023 |
| Annie Yoshiyama | Svp And Finance | 130,322 | 04 Feb, 2026 |
| Deborah M. Messemer | 107,431 | 12 Jun, 2025 | |
| Yinlin Jack Chen | Svp And Finance | 88,881 | 14 Aug, 2023 |
| Stephen Mayo | 25,328 | 09 Aug, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Earl Martin Douglas | Common Stock | D | 22,900 | $1.76 | 564,948 | D | S |
| 02 Feb, 2026 | Geoffrey M. Parker | Common Stock | D | 24,001 | $1.76 | 1,252,795 | D | S |
| 02 Feb, 2026 | David D Chang | Common Stock | D | 95,269 | $1.80 | 5,185,862 | D | S |
| 02 Feb, 2026 | Annie Yoshiyama | Common Stock | D | 4,167 | $1.72 | 130,322 | D | S |
| 02 Feb, 2026 | Zachary Roberts | Common Stock | D | 35,700 | $1.77 | 581,166 | D | S |
| 02 Feb, 2026 | Benjamin Machinas Beneski | Common Stock | D | 7,549 | $1.73 | 210,172 | D | S |
| 21 Jan, 2026 | Zachary Roberts | Common Stock | D | 26,269 | $1.56 | 616,866 | D | S |
| 18 Dec, 2025 | Joshua A Kazam | Common Stock | A | 47,700 | $0.00 | 350,763 | D | M |
| 18 Dec, 2025 | Joshua A Kazam | - | - | 350,763 | D | |||
| 17 Nov, 2025 | Benjamin Machinas Beneski | Common Stock | D | 786 | $1.22 | 217,721 | D | S |
| 21 Oct, 2025 | Geoffrey M. Parker | Common Stock | D | 36,744 | $1.26 | 1,276,796 | D | S |
| 10 Jun, 2025 | Deborah M. Messemer | Common Stock | D | 36,885 | $1.42 | 107,431 | D | S |
| 10 Jun, 2025 | Deborah M. Messemer | - | - | 107,431 | D | |||
| 21 Apr, 2025 | Annie Yoshiyama | Common Stock | D | 9,601 | $1.41 | 130,663 | D | S |
| 21 Apr, 2025 | Annie Yoshiyama | - | - | 130,663 | D | |||
| 14 Mar, 2025 | David D Chang | Common Stock | D | 46,668 | $1.96 | 5,276,569 | D | S |
| 14 Mar, 2025 | Benjamin Machinas Beneski | Common Stock | D | 5,488 | $1.98 | 218,507 | D | S |
| 01 Mar, 2025 | Benjamin Machinas Beneski | - | - | 223,995 | D | |||
| 01 Mar, 2025 | Benjamin Machinas Beneski | Common Stock | A | 31,755 | $0.00 | 223,995 | D | A |
| 18 Feb, 2025 | Deborah M. Messemer | Common Stock | D | 13,313 | $2.43 | 144,316 | D | S |